Concert Pharmaceuticals, Inc. announced the appointment of Wendell Wierenga, Ph.D. to its board of directors. Dr. Wierenga is a seasoned executive with broad experience across all aspects of research, drug discovery and drug development including clinical research, regulatory affairs, manufacturing, safety, and medical affairs. Most recently, Dr. Wierenga served as Executive Vice President of Research and Development of Santarus, Inc.